A separate disease within the syndrome of schizophrenia

Archives of General Psychiatry

Volumn 58, Issue 2, 2001, Pages 165-171

  Kirkpatrick, B ^a   Buchanan, R W ^a   Ross, D E ^a   Carpenter W T , Jr ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

DISEASE COURSE; HUMAN; MENTAL DISEASE; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SYMPTOMATOLOGY;

EID: 0035135656     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.58.2.165     Document Type: Review

References (84)

1. The diagnosis and understanding of schizophrenia, III: Speculations on the processes that underlie schizophrenic symptoms and signs
2. The prediction of outcome in schizophrenia, IV: Eleven-year follow up of the Washington IPSS cohort
3. Three syndromes in chronic schizophrenia
4. Domains of psychopathology: An approach to the reduction of heterogeneity in schizophrenia
5. Negative vs positive schizophrenia: Definition and validation
6. Symptoms of schizophrenia: Methods, meanings, and mechanisms
7. Deficit and nondeficit forms of schizophrenia: The concept
8. The Schedule for the Deficit Syndrome: An instrument for research in schizophrenia
9. Negative symptoms in schizophrenia: Definition and reliability
10. Stability of the diagnosis of deficit syndrome in schizophrenia
11. Testing systems for assessment of negative symptoms in schizophrenia
12. Family characteristics of deficit and non-deficit schizophrenia in the Roscommon Family Study
13. The reliability of distinguishing primary versus secondary negative symptoms
14. Case identification and stability of the deficit syndrome of schizophrenia
15. Depressive symptoms and the deficit syndrome of schizophrenia
16. Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia
17. Diagnosis in schizophrenia and manic-depressive illness: A reassessment of the specificity of "schizophrenic" symptoms in the light of current research
18. Anhedonia and the deficit syndrome of schizophrenia
19. Antecedents, symptoms progression, and long-term outcome of the deficit syndrome in schizophrenia
20. The deficit syndrome in the DSM-IV Field Trial, II: Depressive episodes and persecutory beliefs
21. The deficit syndrome in the Suffolk County Mental Health Project
22. The deficit syndrome in the DSM-IV Field Trial, I: Alcohol and other drug abuse
23. Awareness of dyskinesia in schizophrenia: Relationship to insight into mental illness
24. Clinical correlates of the deficit syndrome of schizophrenia
25. Risk factors for spontaneous dyskinesia in schizophrenia
26. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia
27. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome
28. Pharmacological strategies for treating negative symptoms
29. Negative and deficit symptoms in schizophrenia do respond to neuroleptics
30. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia
31. Risperidone in the treatment of schizophrenia
32. Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
33. Clinical and biologic response to clozapine in patients with schizophrenia: Crossover comparison with fluphenazine
34. Positive and negative symptoms covary during clozapine treatment in schizophrenia
35. Clozapine's effect on negative symptoms in treatment-refractory schizophrenics
36. Clinical effects of clozapine in chronic schizophrenia: Response to treatment and predictors of outcome
37. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia
38. Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia
39. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: A meta-analysis of randomized controlled trials
40. Comparison of efficacy of social skills training for deficit and non-deficit negative symptoms in schizophrenia
41. Family history and deficit form in schizophrenia
42. Family history and obstetric complications in deficit and non-deficit schizophrenia: Preliminary results
43. Risk factors for the deficit syndrome of schizophrenia
44. Sibling correlation of the deficit syndrome in the Irish study of high-density schizophrenia families
45. Borna disease virus antibodies and the deficit syndrome of schizophrenia
46. Positive and negative syndromes, and Borna disease virus infection in schizophrenia
47. Seasonality of births in schizophrenia and bipolar disorder: A review of the literature
48. Summer birth and the deficit syndrome of schizophrenia
49. Month of birth in deficit and non-deficit schizophrenic patients
50. Season of birth: Schizophrenia and bipolar disorder
51. A comparison of plasma homovanillic acid in the deficit and nondeficit sub-types of schizophrenia
52. Schizophrenic patients with deficit syndrome have higher plasma homovanillic acid concentrations and ventricular enlargement
53. Plasma 3-methoxy-4-hydroxyphenylglycol and homovanillic acid measurements in deficit and nondeficit forms of schizophrenia
54. Strong inference, theory testing, and the neuroanatomy of schizophrenia
55. Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, prefrontal and limbic functions
56. Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia
57. Attentional impairments in deficit and nondeficit forms of schizophrenia
58. Neurological signs and the heterogeneity of schizophrenia
59. Mixture distributions in psychiatric research
60. Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees
61. Smooth-pursuit eye movement dysfunction and liability for schizophrenia: Implications for genetic modeling
62. Smooth-pursuit eye tracking in first-episode psychotic patients and their relatives
63. Mixture analysis of pursuit eye-tracking dysfunction in schizophrenia
64. Mixture analysis of smooth pursuit eye movements in schizophrenia
65. Eye tracking disorder in schizophrenia is characterized by specific ocular motor defects and is associated with the deficit syndrome
66. Association of abnormal smooth pursuit eye movements with the deficit syndrome in schizophrenic patients
67. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome
68. Frontal and parietal blood flow activation during an auditory task differentiate schizophrenic patients with and without primary negative symptoms
69. Abnormal smooth pursuit eye movements in schizophrenic patients are associated with cerebral glucose metabolism in oculomotor regions
70. Oculomotor abnormalities and their clinical correlates in schizophrenia
71. Visual information-processing impairments in deficit and nondeficit schizophrenia
72. Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia
73. Cerebral blood flow and mental processes in schizophrenia
74. Patterns of cerebral blood flow in schizophrenia
75. Structural abnormalities in deficit vs non-deficit schizophrenia
76. Frontal and temporal lobe brain volumes in schizophrenia: Relationship to symptoms and clinical subtype
77. The interstitial cells of the white matter in the inferior parietal cortex in schizophrenia: An unbiased cell-counting study
78. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects
79. Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia
80. Strong inference
81. Taxometric methods
82. Taxometric analysis, II: Detecting taxonicity using covariance of two quantitative indicators in successive intervals of a third indicator (MAXCOV procedure)
83. Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features